Heart Alterations after Domoic Acid Administration in Rats

Research Projects

Organizational Units

Journal Issue

Abstract

Domoic acid (DA) is one of the best known marine toxins, causative of important neurotoxic alterations. DA effects are documented both in wildlife and experimental assays, showing that this toxin causes severe injuries principally in the hippocampal area. In the present study we have addressed the long-term toxicological effects (30 days) of DA intraperitoneal administration in rats. Different histological techniques were employed in order to study DA toxicity in heart, an organ which has not been thoroughly studied after DA intoxication to date. The presence of DA was detected by immunohistochemical assays, and cellular alterations were observed both by optical and transmission electron microscopy. Although histological staining methods did not provide any observable tissue damage, transmission electron microscopy showed several injuries: a moderate lysis of myofibrils and loss of mitochondrial conformation. This is the first time the association between heart damage and the presence of the toxin has been observed

Description

Bibliographic citation

Vieira, A.C.; Cifuentes, J.M.; Bermúdez, R.; Ferreiro, S.F.; Castro, A.R.; Botana, L.M. Heart Alterations after Domoic Acid Administration in Rats. Toxins 2016, 8, 68

Relation

Has part

Has version

Is based on

Is part of

Is referenced by

Is version of

Requires

Sponsors

The research leading to these results has received funding from the following Fondo Europeo de Desarrollo Regional (FEDER) cofunded-grants. From Centro para el Desarrollo Tecnológico e Industrial (CDTI) and Technological Funds, supported by Ministerio de Economía y Competitividad, Programa Nacional de Recursos y Tecnologías Agroalimentarias (AGL) AGL2012-40185-CO2-01, AGL2014-58210-R, and Consellería de Cultura, Educación e Ordenación Universitaria, GRC2013-016. From CDTI under India & Spain Innovating Program (ISIP) Programme, Spain, IDI-20130304 APTAFOOD. From the European Union’s Seventh Framework Programme managed by REA—Research Executive Agency (FP7/2007-2013) under grant agreement 312184 PHARMASEA

Rights

© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/)